Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs
September 28, 2023 17:19 ET
|
Biosenta Inc
TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled to announce a pivotal discovery led by Dr. Mehdi Mohammadi Ashani,...
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Filler™
September 06, 2023 10:07 ET
|
Biosenta Inc
CALGARY, Alberta, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE: ZRO) is pleased to announce the next level of partnership with AMPAK Inc. and...
Biosenta announces further advances in research and development of Tri-Filler™
August 08, 2023 16:00 ET
|
Biosenta Inc
TORONTO and CALGARY, Alberta, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is pleased to announce further advances in research and development of the...
Biosenta Announces Termination of Joint Venture and Issuance of Securities
July 17, 2023 07:20 ET
|
Biosenta Inc
TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) is pleased to announce that it has completed its previously announced transaction to terminate its...
Biosenta Announces Entering Into of Agreement to Terminate Joint Venture
June 23, 2023 17:01 ET
|
Biosenta Inc
TORONTO, June 23, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) is pleased to announce that it has come to an agreement (the “Agreement”) with 19443391 Ontario Inc....
Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.
May 31, 2023 18:32 ET
|
Biosenta Inc
CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. ( “Biosenta”) (CSE: ZRO) announces that, further to its news release dated October 12, 2022, it has ceased negotiations with Voran...
Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to collaborate on the commercialization of Biosenta’s Tri-Filler® Products
October 12, 2022 12:11 ET
|
Biosenta Inc
CALGARY, Alberta, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) has signed a milestone Memorandum of Understanding dated October 5, 2022, with VORAN GROUP...
University of Calgary research on Biosenta filler particles yields very encouraging results for the construction industry in the fight against bacteria
May 25, 2022 13:12 ET
|
Biosenta Inc
CALGARY, Alberta, May 25, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) is developing environmentally friendly biocidal particles that are successfully tested...
Biosenta Announces Note Financing
January 28, 2021 14:14 ET
|
Biosenta Inc
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE:ZRO) announces that it will enter into a series of prime plus 5% unsecured promissory...
Biosenta Announces Record Revenues
January 26, 2021 18:29 ET
|
Biosenta Inc
CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360. The Purchase Order is...